Follow the Profound Medical Corp. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €255.7m. The latest transaction was disclosed on 18 August 2026 (00 - Opening Balance-Initial SEDI Report). Among the most active insiders: Jamali, Vafa. The full history is accessible without an account.
37
Insider Decl.
n/a
Thresholds
€38,653
1 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Profound Medical Corp. Strong Buy (bullish), based on 5 analysts. Average price target: US$11.14.
33Σ signal
Buys €38,653n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,876 of 28,803 companies
28.5
score / 100
Value
12
Quality
45
FCF yld-16%
Earn yld-17%
EV/EBITDA·
ROE-74%
Gross mgn71%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
10,000 shares@ CA$9.410.024% mcap100.0% of flowOptionsTSXSEDI:4735383
25 of 37 declarations
About Profound Medical Corp.
Profound Medical Corp. is a company focused on developing medical technologies for the treatment of prostate cancer. It specializes in using thermal energy to target and destroy tumor tissues.